AstraZeneca to tack on another $100M to wrap up over-budget R&D center

AstraZeneca is budgeting another $100 million in 2022 to wrap up work on its R&D center in Cambridge, U.K. The addition brings the total costs of the over-budget and overdue research hub to $1.3 billion.